Clinical Outcome Assessment — Initial Public Discussion

In this presentation from C-Path’s rare and orphan disease program, you will see an overview of patient-focused drug development and endpoints that inform regulatory decision making, a summary of work to date on concepts and tools, as well as next steps for engaging with people with lived experience.

You can view the presentation slides here.

The post Clinical Outcome Assessment — Initial Public Discussion appeared first on C-Path.